Tech Company Financing Transactions

InSightec Funding Round

Koch Disruptive Technologies, Elbit Imaging and Focus Holdings joined a $150 million Series E funding round for InSightec. The round was announced on 12/15/2017.

Transaction Overview

Company Name
Announced On
12/15/2017
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series E
Proceeds Purpose
The investment, announced Thursday, will allow the company to further commercialize its approved indications, as well as continue research in areas such as Parkinson's disease, Alzheimer's disease and brain tumors, using the company's breakthrough technology to deliver treatment in a non-invasive way.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5 Nachum Heth St.
Tirat Carmel, 3912001
Israel
Email Address
Overview
INSIGHTEC is the pioneer of Magnetic Resonance guided Focused Ultrasound (MRgFUS), used for non-invasive treatments in an outpatient setting.
Profile
InSightec LinkedIn Company Profile
Social Media
InSightec Company Twitter Account
Company News
InSightec News
Facebook
InSightec on Facebook
YouTube
InSightec on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Maurice Ferré
  Maurice Ferré LinkedIn Profile  Maurice Ferré Twitter Account  Maurice Ferré News  Maurice Ferré on Facebook
Chief Financial Officer
Roni Karie
  Roni Karie LinkedIn Profile  Roni Karie Twitter Account  Roni Karie News  Roni Karie on Facebook
Founder
Kobi Vortman
  Kobi Vortman LinkedIn Profile  Kobi Vortman Twitter Account  Kobi Vortman News  Kobi Vortman on Facebook
VP - Operations
Baruch Avruch
  Baruch Avruch LinkedIn Profile  Baruch Avruch Twitter Account  Baruch Avruch News  Baruch Avruch on Facebook
VP - Operations
Eyal Zadicario
  Eyal Zadicario LinkedIn Profile  Eyal Zadicario Twitter Account  Eyal Zadicario News  Eyal Zadicario on Facebook
VP - R & D
Moni Carmeli
  Moni Carmeli LinkedIn Profile  Moni Carmeli Twitter Account  Moni Carmeli News  Moni Carmeli on Facebook
VP - Regulatory Affairs
Nadir Alikacem
  Nadir Alikacem LinkedIn Profile  Nadir Alikacem Twitter Account  Nadir Alikacem News  Nadir Alikacem on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/15/2017: Villiger venture capital transaction
Next: 12/15/2017: Relay Therapeutics venture capital transaction

 

Share this article

 


News on VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary